Tuberculosis in elderly persons living in institutions;La tuberculose chez les personnes âgées en institution

Revue des Maladies Respiratoires

Volumn 20, Issue 6 I, 2003, Pages 912-919

  Gisselbrecht, M ^a  

^a HÔPITAL EUROPÉEN GEORGES POMPIDOU   (France)

Author keywords

Elderly Subjects; Institutions; Long Stay; Nursing Homes; Tuberculosis

Indexed keywords

AGE; AGED; CLINICAL FEATURE; CLONAL ANERGY; FRAMESHIFT MUTATION; HEALTH CARE POLICY; HIGH RISK POPULATION; HUMAN; INCIDENCE; INDUSTRIALIZATION; INSTITUTIONAL CARE; LONG TERM CARE; MORTALITY; NURSING HOME; REVIEW; RISK FACTOR; SCREENING; SYMPTOM; TUBERCULOSIS;

AGED; HOMES FOR THE AGED; HUMANS; TUBERCULOSIS, PULMONARY;

EID: 1642513360     PISSN: 07618425     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (45)

1. Decludt B, Campese C: Les cas de tuberculose déclarés en France en 2000. BEH 2002; 16-17: 68-70.
2. Stead WW, Lofgren JP, Warren E, Thomas C: Tuberculosis as an endemic and nosocomial infection among the elderly in nursing homes. N Engl J Med 1985; 312: 1483-7.
3. Infuso A, Antoine D, Barbosa P, Euro TB, Institut de veille sanitaire, pour les correspondants nationaux des pays de la région Europe de l'OMS participant au projet EuroTB: Surveillance européenne de la tuberculose en 1999 et tendances récentes. BEH 2002; 16-17: 66-7.
4. Courson JP, Madinier C: Recensement de la population 1999, la France continue de vieillir. Insee Première 2000; 746: 1-4.
5. Davies PDO: Tuberculosis in the eldely. Drugs aging 1996; 8: 436-44.
6. Dutt AK, Stead WW: Tuberculosis in the elderly. Med Clin North Am 1993; 77: 1353-68.
7. Woo J, Chan HS, Hazlett CB, Ho SC, Chan R, Sham A, Davies PD: Tuberculosis among elderly Chinese in residential homes: tuberculin reactivity and estimated prevalence. Gerontology 1996; 42: 155-62.
8. Bouchon JP: Tuberculose et vieillard. Rev Gériatr 1998; 4: 317-23.
9. Alvarez S, Shell C, Berk SL: Pulmonary tuberculosis in elderly men. Am J med 1987; 82: 602-6.
10. Katz PR, Reichman W, Dube D, Feather J: Clinical features of pulmonary tuberculosis in young and old veterans. J Am Geriatr Soc 1987; 35: 512-5.
11. Liaw YS, Yang PC, Yu CJ, Wu ZG, Chang DB, Lee LN, Kuo SH, Luh KT: Clinical spectrum of tuberculosis in older patients. J Am Geriatr Soc 1995; 43: 256-60
12. Pérez-Guzman C, Vargas MH, Torres-Cruz A, Villarreal-Velarde H: Does aging modify pulmonary tuberculosis? Chest 1999; 116: 961-7.
13. Korzeniewska-Kosela M, Krysl J, Müller N, Black W, Allen E, Fitzgerald JM: Tuberculosis in young adults and the elderly. Chest 1994; 106: 28-32.
14. Chan CHS, Woo J, Or KKH, Chan RCY, Cheung W: The effect of age on the presentation of patients with tuberculosis. Tubercle lung disease 1995; 76: 290-4.
15. Umeki S, Soejima R, Hara Y: Age-dependant alterations in clinical features of pulmonary tuberculosis. Kekkaku 1992; 67: 9-18.
16. Davies PDO: Tuberculosis in the elderly. J Antimicrob Chem 1994; 34: 93A-100A
17. Gisselbrecht M, Diehl JL, Durand H, Lowenstein W, Haas C: Diagnostic d'une pancytopénie fébrile. Rev Med Interne 1996; 17S: 295S-6S.
18. Morris CDW: The radiography, haematology and biochemistry of pulmonary tuberculosis in the aged. Q J Med 1989; 71: 529-36.
19. Diagnostic standards and classification of tuberculosis in adults and children American Thoracic Society. Am J Respir Crit Care Med 2000; 161: 1395-2000.
20. Gonzalez-Rothi RJ: Examining the biology of tuberculosis. Cur Opin Pulmon 1998; 4: 154-61.
21. Al Zahrani K, Al Jadhali H, Poirier L, Rene P, Gennaro ML, Menzies D: Accuracy and utility of commercially available amplification and serologic tests for the diagnosis of minimal pulmonary tuberculosis. Am J Respir Crit Care Med 2000; 162: 1323-9.
22. Del Prete R, Picca V, Mosca A, D'Alagni M, Miragliotta G: Detection of anti-lipoarabinomannan antibodies for the diagnosis of active tuberculosis. Int J Tuberc Lung Dis 1998; 2: 521-2.
23. Ginesu F, Pirina P, Sechi LA, Molicotti P, Santoru L, Porcu L, Fois A, Arghittu P, Zanetti S, Fadda G: Microbiological diagnosis of tuberculosis: a comparaison of old and new methods. J Chemother 1998; 10: 295-300.
24. Lang AM, Feris-Iglesias J, Pena C, Sanchez JF, Stockman L, Rys P, Roberts GD, Henry NK, Persing DH, Cockerill FR: Clinical evaluation of the Gen-Probe amplified direct test for detection of mycobacterium tuberculosis complex in cerebrospinal fluid. J Clin Microbiol 1998; 36: 2191-4.
25. Al Zahrani K, Al Jadhali H, Menzies D: Does size matter? Utility of size of tuberculin reactions for the diagnosis of mycobacterial disease. Am J Respir Crit Care Med 2000; 162: 1419-22.
26. Ijaz K, Dillaha JA, Yang Z, Cave MD, Bates JH: Unrecognized tuberculosis in a nursing home causing death with spread of tuberculosis to the community. J Am Geriatr Soc 2002; 50: 1213-8.
27. Welty C, Burstin S, Muspratt S, Tager IB: Epidemiology of tuberculous infection in a chronic care population. Am Rev Respir Dis 1985; 132: 133-6.
28. Nisar M, Williams CSD, Ashby D, Davies PDO: Tuberculin testing in residential homes for the elderly. Thorax 1993; 48: 1257-60.
29. Langille DB, Sweet LE: Tuberculin skin testing in a hospital and two chronic care facilities in Prince Edward island. Can J Infect Control 1995; 10: 41-4.
30. Alvarez S, Kasprzyk DR, Freundl M: Two-stage skin testing for tuberculosis in a domiciliary population. Am Rev Respir Dis 1987; 136: 1193-6.
31. Aronow WS, Bloom HG: Tuberculosis screening in 1 161 elderly patients. Chest 1989; 96: 961.
32. Tort J, Pina JM, Martin Ramos A, Espaulella J, Armengol J: Booster effect in elderly patients living in geriatric insritutions. Med Clin 1995; 105: 41-4.
33. Sherman RA, Shimoda KJ: Tuberculosis tracking: determining the frequency of the booster effect in patients and staff. Am J Infect Control 2001; 29: 7-12.
34. Stead WW, To T: The significance of the tuberculin skin test in elderly persons. Ann Intern Med 1987; 107: 837-42.
35. Stead WW, To T, Harrison RW, Abraham JH: Benefit-risk considerations in preventive treatment fot tuberculosis in elderly persons. Ann Intern Med 1987; 107: 843-5.
36. Migliori GB, Raviglione MC, Schaberg T, Davies PD, Zellweger JP, Grzemska M, Mihaescu T, Clancy L, Casali L: Tuberculosis management in Europe. Eur Respir J 1999; 14: 978-92.
37. Treatment of tuberculosis. American Thoracic Society, Center for Disease Control and Prevention/Infectious Diseases Society of America. Am J Respir Crit Care Med 2003; 167: 603-62.
38. Chemotherapy and management of tuberculosis in the United Kingdom: recommandations 1998. Thorax 1998; 53: 536-48.
39. Targeted tuberculin testing and treatment of latent tuberculosis infection: American Thoracic Society. Am J Respir Crit Care Med 2000; 161: S221-S247.
40. Fatal and severe liver injuries associated with rifampicin and pyrazinamide for latent tuberculosis infection, and revisions in American Thoracic Society/CDC recommendations-United States, 2001. Am J Respir Crit Care Med 2001; 164: 1319-20.
41. Janssens JP, Zellweger JP: Epidémiologie clinique et traitement de la tuberculose chez les personnes âgées. Schweiz Med Wochenschr 1999; 129: 80-9.
42. Schaberg T, Rebhan K, Lode H: Risk factors for side-effects of isoniazide, rifampicin and pyrazinamide in patients hospitalized for pulmonary tuberculosis. Eur Respir J 1996; 9: 2026-30.
43. Van den Brande P, Van Steenbergen W, Vervoort G, Demedts M: Aging and hepatotoxicity of isoniazid and rifampicin in pulmonary tuberculosis. Am J Respir Crit Care Med 1995; 152: 1705-8.
44. Humphries MJ, Byfield SP, Darbyshire JH, Davies PD, Nunn AJ, Citron KM, Fox W: Deaths occuring in newly notified patients with pulmonary tuberculosis in England and Wales. Br J Dis Chest 1984; 78: 149-58.
45. Barnes PF, Leedom JM, Chan LS, Wong SF, Shah J, Vachon LA, Overturf GD, Modlin RL: Predictors of short-term prognosis in patients with pulmonary tuberculosis. J Infect Dis 1988; 158: 366-71.